Assessing Remote Confirmation of Type 1 Diabetes
Launched by ROYAL DEVON AND EXETER NHS FOUNDATION TRUST · Feb 10, 2025
Trial Information
Current as of August 28, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Background It can be hard to diagnose type 1 diabetes in adults because the symptoms can overlap with type 2 diabetes and misclassification of type 2 and type 1 diabetes can occur. This matters as type 2 diabetes cases misclassified as having type 1 diabetes potentially receive a lifetime of unnecessary insulin treatment without access to the effective treatment strategies for type 2 diabetes. Whether someone needs treating as type 1 diabetes can be confirmed by measuring their insulin levels using a test called C-peptide. This should be measured when diabetes is longstanding (over 3 years ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with a Type 1 diabetes follow up code OR rapid progression to insulin (within 3 years of diagnosis) to capture miscoded cases.
- • Under the clinical care of the diabetes team(s) at the Royal Devon University Healthcare NHS Foundation Trust
- • Duration of diabetes \>3 years
- • Aged 18 years or older.
- Exclusion Criteria:
- • Patients considered by their clinical care team to be unsuitable/inappropriate to be invited to take part in this research (e.g. severe sight impairment, reduced capacity to consent)
About Royal Devon And Exeter Nhs Foundation Trust
The Royal Devon and Exeter NHS Foundation Trust is a leading healthcare organization dedicated to delivering high-quality patient care and advancing medical research. Located in Exeter, the Trust is committed to innovation and excellence in clinical trials, facilitating studies that aim to improve health outcomes and enhance treatment options across various medical disciplines. With a strong emphasis on collaboration, the Trust partners with researchers, healthcare professionals, and patients to foster a research environment that prioritizes safety, ethical standards, and scientific integrity. Through its robust infrastructure and expertise, the Royal Devon and Exeter NHS Foundation Trust plays a vital role in the advancement of evidence-based medicine and the translation of research findings into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Exeter, Devon, United Kingdom
Patients applied
Trial Officials
Nicholas Thomas, PhD MRCP
Principal Investigator
University of Exeter and Royal Devon University Healthcare NHS Foundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported